Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2012
06/07/2012US20120144515 Cucurbita pepo hybrids
06/07/2012US20120144513 Lettuce Variety Salmon
06/07/2012US20120144511 Muteins of the pyrroline-5-carboxylate reductase 1
06/07/2012US20120144510 Treatment of astrocytes-tumor cells inhibitors of endothelin receptors
06/07/2012US20120142907 Modified macromolecules and associated methods of synthesis and use
06/07/2012US20120142776 Methods and compositions for inducing physiological hypertrophy
06/07/2012US20120142765 Sphingosine-bound siRNA
06/07/2012US20120142764 Multi-Cistronic shRNA Expression Cassette for Suppressing Single or Multiple Target Genes
06/07/2012US20120142763 Nucleic acid delivery compositions and methods of use thereof
06/07/2012US20120142761 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142759 Soluble thf receptors and their use in treatment of disease
06/07/2012US20120142758 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
06/07/2012US20120142757 RNAi Modulation of AHA and Therapeutic Uses Thereof
06/07/2012US20120142756 mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
06/07/2012US20120142755 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation
06/07/2012US20120142731 Methods of inhibiting viral infection
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142626 Compounds
06/07/2012US20120142619 Medicinal carbohydrates for treatment of respiratory conditions
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142611 Repeat protein from collection of repeat proteins comprising repeat modules
06/07/2012US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/07/2012US20120142604 Novel applications of hip/pap or derivatives thereof
06/07/2012US20120142603 Bioadhesive patch for sutureless closure of soft tissue
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142593 Factor VIII Variants and Methods of Use
06/07/2012US20120142544 Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies
06/07/2012US20120142110 Method of Genetically Altering and Producing Allergy Free Cats
06/07/2012US20120142109 Method for producing t cell population under presence of retinoic acid
06/07/2012US20120142107 Method and system for somatic cell nuclear transfer
06/07/2012US20120142106 Method Of Forming Dendritic Cells From Embryonic Stem Cells
06/07/2012US20120142105 Production and extraction of procyanidins from plant cell cultures
06/07/2012US20120142104 Supplement for cell cultivation media
06/07/2012US20120142103 Method for inducing differentiation into epithelial progenitor cell/stem cell population and corneal epithelial cell population from induced pluripotent stem cells
06/07/2012US20120142102 Isolation of human umbilical cord blood-derived mesenchymal stem cells
06/07/2012US20120142101 Oligonucleotide end caps
06/07/2012US20120142100 Heat shock rna from various species and its use in activation of heat shock transcription factor, in treatment of various diseases in animals and in generation of stress-resistant plants
06/07/2012US20120142099 Novel bak binding protein, dna encoding the protein, and methods of use thereof
06/07/2012US20120142098 Fc receptor-binding polypeptides with modified effector functions
06/07/2012US20120142097 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120142096 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120142095 Technique for determining the state of a cell aggregation image processing program and image processing device using the technique, and method for producing a cell aggregation
06/07/2012US20120142094 Generating ips cells by protein transduction of recombinant potency-determining factors
06/07/2012US20120142093 Method for inducing differentiation of pluripotent stem cells into neural precursor cells
06/07/2012US20120142092 Rat embryonic stem cell
06/07/2012US20120142091 Antibodies Against Human Angiopoietin 2
06/07/2012US20120142090 Protein Expression System
06/07/2012US20120142089 Method of separating target cell in biological sample
06/07/2012US20120142088 Dna-cell conjugates
06/07/2012US20120142079 Minicell based delivery of biologically active compounds
06/07/2012US20120142072 Soluble protein and utilization of the same
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120142063 Nitrilase biocatalysts
06/07/2012US20120142062 Engineered cleavage half-domains
06/07/2012US20120142057 Method for production of polypeptide
06/07/2012US20120142056 MAMMALIAN EXPRESSION VECTOR pUHAB
06/07/2012US20120142052 Method and device for multiple feed cultivation
06/07/2012US20120142049 Recombinant Gene Expression
06/07/2012US20120142042 Selective Delivery Of Molecules Into Cells Or Marking Of Cells In Diseased Tissue Regions Using Environmentally Sensitive Transmembrane Peptide
06/07/2012US20120142029 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
06/07/2012US20120142022 Glycosylated mammalian ngal and use thereof
06/07/2012US20120142018 Rapid Single Cell Based Parallel Biological Cell Sorter
06/07/2012US20120142008 Methods for evaluating gastrointestinal absorption of chemicals
06/07/2012US20120142002 Spontaneously immortalized multicomponent mesenchymal cell-line derived from mouse subcutaneous adipose tissue: tool for regenerative medicine and bioactive molecules and/or drugs screening
06/07/2012US20120141984 Methods of isolating stem cells
06/07/2012US20120141982 Culture Method for Obtaining a Clonal Population of Antigen-Specific B Cells
06/07/2012US20120141975 Blood component separation system and separation material
06/07/2012US20120141628 Method for the prevention or reduction of haze in beverages
06/07/2012US20120141595 Umbilical cord amniotic membrane products
06/07/2012US20120141573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses Thereof
06/07/2012US20120141559 Bio-membrane for tissue regeneration
06/07/2012US20120141552 Ultrasound technology to control the spatial organization of cells and proteins in engineered tissues
06/07/2012US20120141547 Methods of making cell sheets, tissue sheets and tissue engineered blood vessels
06/07/2012US20120141540 Drug Delivery System
06/07/2012US20120141539 Methods for modulating toll-like receptor mediated activation of cells of the innate system by modulating xbp-1 activity
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
06/07/2012US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141501 Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof
06/07/2012US20120141491 Methods and compositions for the treatment of cancers and pathogenic infections
06/07/2012US20120141490 Antibodies That Bind Selectively To P25 And Uses Therefor
06/07/2012US20120141487 Moraxella catarrhalis antigens
06/07/2012US20120141486 Human monoclonal antibody
06/07/2012US20120141482 Molecular complexes which modify immune responses
06/07/2012US20120141480 Methods of treating with anti-factor d antibodies
06/07/2012US20120141469 Cripto antagonism of activin and tgf-b signaling
06/07/2012US20120141466 Composition and method for treatment of reperfusion injury and tissue damage
06/07/2012US20120141462 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
06/07/2012US20120141460 Method for the production of variable domains
06/07/2012US20120141456 Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
06/07/2012US20120141453 Glycosidase Enzymes
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141440 Foamyvirus vectors and methods of use
06/07/2012US20120141438 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
06/07/2012US20120141437 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells
06/07/2012US20120141436 Compositions and methods for promoting beta cell maturity
1 ... 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 ... 1827